期刊文献+

急性冠脉综合征患者血清载脂蛋白A5水平及相关因素分析 被引量:5

Analysis of serum apolipoprotein A5 level and related factors for patients with acute coronary syndrome
下载PDF
导出
摘要 目的对急性冠脉综合征(ACS)患者血清载脂蛋白A5(Apo A5)水平及相关因素进行分析。方法选取2014年7月—2015年6月在瑞金医院卢湾分院心内科就诊患者188例作为研究对象。按国际指南ACS诊断标准分为ACS组96例和非ACS组(对照组)92例,ELISA法检测血清Apo A5水平,同时测定血脂谱、血常规、肾功能、血糖、心肌肌钙蛋白I(cTn Ⅰ)及N末端脑钠肽前体(NT-pro BNP)水平,根据ACS组患者的冠脉造影结果计算Gensini评分,围绕Apo A5展开相关性分析。结果 ACS组血清Apo A5水平显著低于对照组(P=0.022)。总体样本中,Apo A5与三酰甘油、游离脂肪酸、cTnⅠ呈等级负相关,与高密度脂蛋白和Apo A1呈等级正相关。分组分析显示:在ACS组,Apo A5与c Tn Ⅰ和冠脉Gensini评分呈高度负相关(P=0.006 9,P=0.014);对照组Apo A5与c Tn Ⅰ无关联(P=0.079)。结论与非ACS患者比较,ACS患者血清Apo A5水平降低,且与心肌损伤和冠状动脉病变程度显著相关。 Objective To analyze the serum apolipoprotein A5 (ApoA5) level and related factors for patients with acute coronary syndrome (ACS). Methods A total of 188 patients who visited the Department of Cardiology of Ruijin Hospital Luwan Branch from July, 2014 to June, 2015 were enrolled and assigned to the ACS group ( n =96) and the non-ACS group (control group, n =92) according to the international guideline for ACS diagnosis criteria. Serum ApoA5 level was measured by ELISA and lipid profile, hemogram, creatinine, uric acid, blood glucose, cardiac troponin I (cTn I), and NT-proBNP were also detected. Gensini scores were calculated according to the results of coronary angiography for patients in the ACS group. Correlation analysis was performed based on ApoAS. Results The ApoA5 level in the ACS group was significantly lower than that in the control group (P=O. 022). For all samples, ApoA5 was negatively correlated to TG, FFA, and cTn I and positively correlated to HDL and ApoA1. Subgroup analyses showed that ApoA5 was highly and negatively correlated to cTn I and coronary artery Gensini score in the ACS group (P=0. 006 9, P=0. 014), whereas ApoA5 was not correlated to cTn I in the control group (P=0. 079). Conclusion The serum ApoA5 level in ACS patients is significantly lower than that in the patients without ACS and ApoA5 is significantly correlated to myocardial injury and the degree of coronary artery disease.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2016年第4期604-608,共5页 Journal of Shanghai Jiao tong University:Medical Science
关键词 冠状动脉粥样硬化性心脏病 载脂蛋白A5 急性冠脉综合征 心肌肌钙蛋白Ⅰ coronary atherosclerotic heart disease apolipoprotein A5 acute coronary syndrome cardiac troponin I
  • 相关文献

参考文献25

  • 1Wei H J, Li YH, Shi GY, et al. Thrombomodulin domains attenuate atherosclerosls by inhibiting thrombin-lndueed endothelial cell acti- vation[J]. Cardiovasc Res, 2011, 92(2): 317 -327.
  • 2Kalz J, Ten Cate H, Spronk HM. Thrombln generation and athero- sclerosis [ J ]. J Thromb Thrombolysis, 2014, 37 ( 1 ) : 45 - 55.
  • 3Beppu T, Gil-Bernabe P, Boveda-Ruiz D, et al. High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient mice[J]. J Thromb Haemost, 2010, 8(11): 2514 -2522.
  • 4Henareh L, Jedefors C, Jogestrand T, et al. Intima-media thickness of common carotid and brachial arteries and prothrombin fragment 1 + 2 are associated with left ventrieular diastolic dysfunction in patients with myocardial infarction [ J ]. Eehoeardiography, 2010, 27(6): 651 -658.
  • 5Luszczak J, Undasa A, Gissel M, et al. Activated factor Ⅺ and tissue factor in aortic stenosis : links with thrombin generation [ J ]. Blood Coagul Fibrinolysis, 2011, 22(6) : 473 -479.
  • 6Quinn TJ, Gallaeher J, Deary IJ, et al. Association between circu- lating hemostatic measures and dementia or cognitive impairment: systematic review and nleta-analyzes [ J ]. J Thromb Haemost, 2011, 9(8) : 1475 -482.
  • 7Miyata M, Ikeda Y, Nakamura S, et al, Effects of valsartan on fibrinolysis in hypertensive patients with metabolic syndrome [ J ]. Cite J, 2012, 76(4) : 843 -851.
  • 8Narverud I, Iversen PO, Aukrust P,et al. Maternal familial hyper- cholesterolaemia (FH) confer sahered haemostatic profile in offspring with and without FH [ J ]. Thromb Res, 2013,131 ( 2 ) : 178 - 182.
  • 9Benes P, Muzik J, Benedik J,et al. Single effects of apolipoprotein B, (a), and E polymorphisms and interaction between plasminogen activator inhibitor-1 and apolipoprotein(a) genotypes and the risk of coronary artery disease in Czech male Caucasians [ J]. Mol Genet Metab, 2000, 69(2): 137- 143.
  • 10Rahimi Z, Vaisi-Raygani A, Pourmotabbed T. Association between apolipoprotein e4 allele, factor V Leiden, and plasma lipid and lipoprotein levels with sickle cell disease in Southern lran [ J]. Mol Biol Rep, 2011, 38(2) : 703 -710.

二级参考文献43

  • 1谭小进,王岳林.冠心病患者心电图ST段水平延长与冠状动脉狭窄程度的相关性及诊断价值[J].中国动脉硬化杂志,2004,12(6):710-712. 被引量:12
  • 2Garelnabi M, Lor K, Jin J, et al. The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research[J]. Clin Biochem,2013,46(1-2):12-19.
  • 3Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing[J]. Science, 2001,294(5540): 169-173.
  • 4van der Vliet HN, Sammels MG, Leegwater AC, et al. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration[J]. J Biol Chem, 2001,276(48):44512-44520.
  • 5Merkel M, Loeffler B, Kluger M, et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipopro- teins by interaction with proteoglycan-bound lipoprotein lipase[J]. J Biol Chem,2005,280(22):21553-21560.
  • 6Kwiterovich PO Jr. Diagnosis and management of familial dyslipoproteinemias[J]. Curr Cardiol Rep,2013,15(6):371.
  • 7Weinberg RB, Cook VR, Beckstead JA, et al. Structure and interfacial properties of human apolipoprotein A-V[J]. J Biol Chem,2003,278(36):34438-34444.
  • 8Sharma V, Forte TM, Ryan RO. Influence of apolipoprotein A-V on the metabolic fate of triacylgly- cerol[J]. Curr Opin Lipidol,2013,24(2):153-159.
  • 9Schaap FG, Rensen PC, Voshol PJ, et al. ApoAV reducesplasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis[J]. J Biol Chem,2004,279(27):27941-27947.
  • 10Chien KL, Hsu HC, Chen YC, et al. Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis[J]. Transl Res,2009,154(3):133-141.

共引文献2

同被引文献51

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部